ArticleBMC bioinformatics2025
MDG-DDI: multi-feature drug graph for drug-drug interaction prediction.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Graph-Based Machine Learning for Predicting Drug-Drug Interactions: A Systematic Review.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Early prediction and risk assessment of adverse drug combinations using ensemble learning.Scientific reports · 2026Article
- Model-Informed Drug Development (MIDD) for Analgesics: Review of Applications, Regulatory Integration, and Emerging Directions.Journal of pain research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundDrug-drug interactions (DDIs) frequently occur in combination therapy and may cause adverse effects or reduced efficacy. Existing computational approaches often fail to capture both the semantic information in drug sequences and the structural properties of drug molecules, limiting predictive power.
resultsWe propose MDG-DDI, a deep learning framework that integrates a Frequent Consecutive Subsequence (FCS)-based Transformer encoder with a Deep Graph Network (DGN) to extract complementary semantic and structural features. These representations are fused and fed into a Graph Convolutional Network (GCN) for DDI prediction. Experiments on three benchmark datasets under transductive and inductive settings show that MDG-DDI consistently outperforms state-of-the-art methods, with particularly strong gains when predicting interactions involving unseen drugs.
conclusionBy jointly modeling substructure-level semantics and molecular graph structure, MDG-DDI achieves robust and accurate DDI prediction. The framework demonstrates improved generalization and offers potential for enhancing drug safety assessment and discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.